← Back to headlines
BNP Paribas Downgrades Sanofi Due to Unlikely Near-Term Rerating
BNP Paribas has downgraded Sanofi, citing an unlikely near-term rerating for the pharmaceutical company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
33m ago
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
39m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
53m ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago